Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Date:11/2/2009

oyee stock-based compensation expense recorded in the third quarter of 2009 totaled $3.3 million. Of these non-cash charges, $0.7 million was recorded as R&D expense and $2.6 million was recorded as G&A expense. For the second quarter of 2009 and the third quarter of 2008, total stock-based compensation expense was $2.8 million and $3.6 million, respectively. The increase in stock-based compensation expense in the third quarter of 2009 relative to the second quarter of 2009 is the result of the issuance of additional non-qualified stock options in 2009. The decrease in stock-based compensation expense in the third quarter of 2009 relative to the third quarter of 2008 is primarily due to a lower stock-based compensation expense resulting from the workforce reduction in the fourth quarter of 2008.
  • Cash and marketable securities decreased by $8.3 million during the third quarter of 2009. Changes included $7.7 million of net losses, increases of $0.5 million in inventory, decreases in accrued expenses and accounts payable of $2.9 million, increases in prepaid expenses of $1.5 million, offset by $3.9 million in non-cash depreciation, amortization, and stock-based compensation expense and $0.4 million in proceeds from the exercise of stock options.
  • Vanda's cash, cash equivalents and marketable securities as of September 30, 2009 totaled approximately $20.7 million, compared to approximately $46.5 million as of December 31, 2008.
  • Net loss for the third quarter of 2009 was $7.7 million, compared to a net loss of $12.4 million for the second quarter of 2009 and a net loss of $10.9 million for the third quarter of 2008.
  • Net loss per common share for the third quarter of 2009 was $0.28, compared to $0.46 for the second quarter of 2009 and $0.41 for the third quarter of 2008.

FINANCIAL GUIDANCE

Vanda is currently c
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
2. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
3. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
4. Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP
5. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
6. Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
7. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
8. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
9. Vanda Pharmaceuticals VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
10. Vanda Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 8, 2007
11. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
(Date:4/17/2014)... synthetic biology team has created a new technology ... that could travel the body and selectively target ... cell-based, biological devices that monitor and modify human ... biology. However, no existing technology enabled bioengineers to ... state and respond in a customized fashion. , ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... 16, 2014) The cause of neuronal death in ... proposes that neurons may be mistaken for foreign invaders ... to the way autoimmune diseases like type I diabetes, ... The study was published April 16, 2014, in ... likely controversial, idea in Parkinson,s disease; but if true, ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... The Hour-Long Special Narrated by Glenn Close Premieres November 18 at ... AM ... Nearly every society on earth is,affected by diabetes -- one of ... million people worldwide are,living with the disease, a number that is ...
... Fire Sabotage Is Latest Attack on Striking Nurses, ... 700,striking nurses at Appalachian Regional Health Care (ARH), ... American Nurses,AFL-CIO, are speaking out to call public ... them by the hospital during their strike,which began ...
... California youth have,teamed up with doctors, teachers, ... for announcing its intent to stop selling,Rockstar 21, ... on Alcopops and Youth is calling on Anheuser ... drinks to follow,Rockstar,s lead. Sold in brightly ...
... sure why mortality may be tied to weight , , MONDAY, ... much weight spells health problems, new research suggests that fat ... with prostate cancer than men of normal weight. , The ... higher risk of death from prostate cancer, and it,s not ...
... California San Francisco has identified distinct molecular markers that ... develop subsequent invasive cancer after initial diagnosis with a ... by Cell Press in the November issue of Cancer ... determine whether a woman should receive more or less ...
... and scientists,from around the world gathered for the ... Florida. The Symposium was,hosted by the Ringling Bros. ... the International Elephant Foundation (IEF), and was,held in ... Elephant,Tuberculosis Research. The Conference brought together experts in ...
Cached Medicine News:Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 2Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 3Health News:Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic 4Health News:Nurses Protest Violent Tactics Against Picketers 2Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 2Health News:Youth and Community Groups Commend Rockstar for Taking 'The Buzz' out of its Energy Drinks 3Health News:Obesity Linked to Prostate Cancer Death Rates 2Health News:Obesity Linked to Prostate Cancer Death Rates 3Health News:Biomarkers predict risk for invasive breast cancer years before the tumor develops 2Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 2Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 3Health News:Conference on Elephant Tuberculosis Research Establishes Action Plan at International Symposium on Elephant Conservation 4
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer for ... As a result of the waiver, the transaction is ... the tender offer on January 24, 2014 following the currently scheduled ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2
... company Hatchtech Pty Ltd has completed treatment of subjects ... efficacy of its novel head lice treatment DeOvo™. ... safety and tolerability of two dose levels of a ... consists of treating 132 healthy subjects with head lice ...
... This evening, Novo Nordisk awarded sponsorships totaling $100,000 to ... people living with type 2 diabetes on how to ... long-term diabetes related complications. The sponsorships are part of ... promote enduring, sustainable change for people living with diabetes. ...
Cached Medicine Technology:Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 2Hatchtech Completes Treatment Phase of 2b Clinical Trial of New-Generation Head Lice Treatment Deovo™ 3Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs 2
... Oxyflo is a highly featured laser ... microvascular blood perfusion from multiple tissue ... developments in Digital Signal Processing (DSP) ... technologically advanced, yet simple to use, ...
... a highly featured laser doppler system ... perfusion from multiple tissue sites. This ... Digital Signal Processing (DSP) and laser ... yet simple to use, multi-channel monitor, ...
Transcranial vascular DWL doppler....
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Medicine Products: